Skip to main content
. 2021 Feb 8;11:608199. doi: 10.3389/fphar.2020.608199

TABLE 11.

Pharmacokinetic parameters of bentysrepinine, M8 and M9 in a multiple doses study (Study 02).

Analyte Dose (mg) Day Cmax (ng/ml) Cmin (ng/ml) Tmax (h) t1/2 (h) AUC0-t (ng·h/ml) CL/F (l/h) V/F (L) R1 R2
Bentysrepinine 300 1 521.2 (162.7) 0.88 (0.50–5.00) 1.6 (0.4) 1,314.6 (209.5) 229.4 (34.0) 535.3 (185.7)
300 9 607.3 (120.8) 5.0 (1.5) 1.00 (0.50–2.00) 3.6 (5.9) 1,436.3 (211.2) 212.0 (31.1) 535.3 (185.7) 1.10 (0.20) 1.10 (0.20)
600 1 1,368.7 (431.4) 1.50 (0.50–2.50) 3.7 (2.4) 3,507.8 (765.5) 175.5 (32.2) 883.5 (577.3)
600 9 1769.4 (636.1) 5.9 (2.4) 1.25 (0.50–2.50) 2.8 (1.4) 3,793.4 (1,218.5) 169.6 (45.2) 722.2 (494.7) 1.33 (0.37) 1.09 (0.26)
M8 300 1 1,687.5 (364.2) 4.00 (2.00–6.00) 6.2 (3.9) 11,515.0 (2,156.9) 26.6 (4.7) 239.9 (166.4)
300 9 1866.1 (259.1) 33.9 (11.4) 3.00 (2.50–6.00) 10.3 (4.4) 12,762.0 (2,336.0) 25.2 (4.4) 379.0 (194.8) 1.13 (0.19) 1.10 (0.14)
600 1 3,290.8 (776.2) 3.50 (2.50–4.00) 8.2 (2.5) 23,158.8 (4,050.4) 26.4 (4.4) 312.0 (110.9)
600 9 3,763.3 (938.8) 85.6 (23.6) 3.00 (2.00–4.00) 8.6 (4.8) 25,475.0 (5,021.0) 25.5 (5.1) 308.3 (149.3) 1.15 (0.17) 1.10 (0.10)
M9 300 1 186.9 (47.6) 5.50 (4.00–6.00) 4.3 (1.2) 1,639.5 (345.3) 192.2 (57.5) 1,161.4 (368.1)
300 9 230.6 (60.4) 4.9 (1.6) 4.00 (4.00–6.00) 7.1 (4.8) 1908.3 (417.0) 172.3 (47.5) 1826.4 (1,368.1) 1.25 (0.21) 1.15 (0.12)
600 1 485.6 (215.6) 4.00 (4.00–6.00) 5.9 (1.9) 3,919.6 (1,282.2) 169.6 (60.3) 1,430.3 (626.5)
600 9 595.3 (290.2) 14.0 (3.9) 4.00 (3.00–5.00) 6.2 (2.3) 4,745.6 (1894.3) 148.4 (52.5) 1,329.4 (546.4) 1.24 (0.22) 1.22 (0.21)

The data are expressed as mean (SD). R1 = Cmax ss/Cmax; R2 = AUC 0-τ ss/AUC 0-τ.